Skip to Content

RDY 250 (Terbinafine 250 mg)

Pill imprint RDY 250 has been identified as Terbinafine 250 mg.

Terbinafine is used in the treatment of onychomycosis, toenail; tinea corporis; cutaneous candidiasis; tinea capitis; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Terbinafine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Terbinafine 250 mg RDY 250
Discount Card Promo
Terbinafine
Imprint:
RDY 250
Strength:
250 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0250
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5944 A-S Medication Solutions, LLC (repackager)
21695-0630 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide